- GMP and Compliance
- Pharmaceutical Product Development
- Development of Stability-Indicating HPLC Methods
- HPLC Analytical Method Development and Validation
- Hands-on Tablet Development including the principles of pre-formulation, formulation and process dev
- Pharmaceutical Dissolution Testing
- Pharmaceutical Dissolution Testing - a Hands-on course
- Pharmaceutical Packaging - an introductory course
- Pharmacokinetics in Drug Development - an integrated approach
- Powder Technology for Pharmaceutical Development and Manufacturing
- Preformulation Studies for Tablet Development
- QbD and Lifecycle Management for Analytical Methods
- Stability Testing in Pharmaceutical Development and Manufacture
- Tablet Formulation Development
- Tablet Process Development, Validation and the Application of QbD
- Technology Transfer
- Pharmaceutical Manufacturing Support
- Pharmaceutical R&D Support
- In-house Training Courses
Development of Stability-Indicating HPLC Methods
|Tutor : Roland Collicott|
|27 June 2016||London|
£540 + Vat
Book now for early bird price
Before 25 April 2016
Stability testing is an essential part of drug development which ensures the quality, safety and efficacy of the drug for the lifetime of the drug product.
Appropriate storage conditions can only be assessed once a stability study has been conducted and it is never too early to start gathering stability data. Stability studies are a pharmacopoeial requirement and guidance is provided by regulatory authorities, including ICH.
This course provides a comprehensive review of the considerations relevant to developing a stability-indicating analytical method, principally focussing on analysis by HPLC. This three day course starts by anticipating likely degradation based on chemical structure. Consideration is then given to forced degradation (stress study) to produce likely degradants, followed by the selection of an HPLC method which is capable of resolving any degradants that have been formed. Finally, the course deals with optimisation and validation of the stability-indicating method.
Upon completion of this course, delegates will have learned what is necessary to develop and validate stability-indicating methods for drug substance and drug product to comply with international regulatory guidelines.
Who Should Attend?
Scientists who need to develop methods for stability testing with maximum efficiency. Scientists who have to produce validated stability-indicating HPLC methods in accordance with current internationally-accepted guidance. HPLC technicians working in R&D laboratories and stability testing laboratories. Managers with a responsibility for generating regulatory submissions.
Overview of developing a stability-indicating method
- Regulatory framework
- What can go wrong on storage"
- Real-time, accelerated and forced degradation
- Chemical and photochemical decomposition
- Requirements for a stability-indicating analytical method
- Stress testing objectives
- Anticipation of likely degradation products
- Common degradation pathways
- Are degradation products likely to be isomers, enantiomers or diastereoisomers"
Workshop: Anticipation of likely degradation products
- Forced degradation (stress testing) of drug substance, as per ICH guidance
- How much degradation is enough" When do we stop"
- Note findings of stress-testing industry comparison
- Brief overview of HPLC theory
- Common modes of HPLC: Reversed and normal phase HPLC
- Different approaches to stability analysis using HPLC
- Determination of degradants and HPLC assay calculation
- Mass balance
Essentials of the stability-indicating HPLC method
- Is the method doing everything I need"
Workshop: Selecting the Separation Mode for a Stability Indicating HPLC Method and Consideration of Detection Issues